Linear IgA bullous dermatosis in a diabetic patient with chronic renal failure

2002 ◽  
Vol 41 (11) ◽  
pp. 778-780 ◽  
Author(s):  
Agnieszka Beata Serwin ◽  
Hanna Myśliwiec ◽  
Halina Laudańska ◽  
Bożena Chodynicka
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Diabetic Patient ◽  
Bullous Dermatosis ◽  
Linear Iga Bullous Dermatosis

scholarly journals Grover’s disease: a rare bullous dermatosis spontaneously regressing

2021 ◽  
Vol 5 (4) ◽  
pp. 75-77
Author(s):  
Sara Bouadella
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Skin Eruption ◽  
Female Patient ◽  
Hematological Malignancies ◽  
Middle Aged ◽  
Fever Episode ◽  
Bullous Dermatosis ◽  
Grover’S Disease

Grover's diseaseis an itchy acantholytic disorder occurring on the trunk of middle-aged men. It is a transient dermatosis of unknown cause manifesting clinically as a papular skin eruption located usually on the anterior chest and abdomen and histologically with dyskeratosis and acantholysis. This disease has occasionally been reported in patients with chronic renal failure, some infections, hematological malignancies, and many other anomalies. We report herein a new case of Grover's disease that developed in a female patient after a fever episode.

scholarly journals Penile Necrosis by Calciphylaxis in a Diabetic Patient with Chronic Renal Failure

2007 ◽  
Vol 46 (13) ◽  
pp. 985-990 ◽  
Author(s):  
Akio Ohta ◽  
Shintaro Ohomori ◽  
Tomoko Mizukami ◽  
Ryusei Obi ◽  
Yasushi Tanaka
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Diabetic Patient

scholarly journals Pseudoporphyria Associated with Nonhemodialyzed Renal Insufficiency, Successfully Treated with Oral N-Acetylcysteine

2013 ◽  
Vol 2013 ◽  
pp. 1-3
Author(s):  
A. C. Katoulis ◽  
D. Ferra ◽  
E. Toumbis ◽  
E. Papadavid ◽  
A. Kanelleas ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Impairment ◽  
Renal Insufficiency ◽  
Porphyria Cutanea Tarda ◽  
Bullous Dermatosis

Pseudoporphyria (PP) is a relatively rare, photodistributed bullous dermatosis that resembles porphyria cutanea tarda (PCT), but it is not accompanied by porphyrin abnormalities in the serum, urine, or stool. It was initially described in renal failure patients on dialysis. Thereafter, it has been associated with several aetiological factors. We report a case of PP in a 67-year-old woman with mild renal failure, successfully treated with N-acetylcysteine. This is the second reported case of PP developing in nondialyzed chronic renal failure. Such cases support the view that renal impairment itself may play a more important aetiological role in developing PP than it was originally considered.

Bullous dermatosis of chronic renal failure

1976 ◽  
Vol 95 (5) ◽  
pp. 541-546 ◽  
Author(s):  
KALMAN KECZKES ◽  
MALCOLM FARR
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Bullous Dermatosis

Bullous Dermatosis among Patients with Chronic Renal Failure on High Dose Frusemide

2009 ◽  
Vol 202 (1-6) ◽  
pp. 61-64 ◽  
Author(s):  
Gerhard Heydenreich ◽  
Torben Pindborg ◽  
Henning Schmidt
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
High Dose ◽  
Bullous Dermatosis

Use of Octreotide to Treat Prolonged Sulfonylurea-induced Hypoglycemia in a Patient with Chronic Renal Failure

2003 ◽  
Vol 26 (1) ◽  
pp. 86-89 ◽  
Author(s):  
C.M. Nzerue ◽  
J. Thomas ◽  
J. Volcy ◽  
T. Edeki
Keyword(s):  
Renal Failure ◽  
Blood Glucose ◽  
Chronic Renal Failure ◽  
Diabetic Patient ◽  
Prospective Studies ◽  
Complete Recovery ◽  
Somatostatin Analogue ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Analogue Octreotide

A diabetic patient with chronic renal failure who developed recurrent and prolonged episodes of hypoglycemia associated with use of sulfonylurea agent is presented here. This patient was hospitalized with neuroglycopenic symptoms of hypoglycemia that persisted in spite of large doses of parenteral glucose replacement. On administration of somatostatin analogue octreotide, hypoglycemia resolved and, blood glucose levels were maintained even after cessation of parenteral glucose. The patient received 2 subcutaneous doses of octreotide 12 hours apart, and made a complete recovery. Our experience suggests that use of octerotide to treat refractory or prolonged sulfonylurea-included hypoglycemia in renal failure patients is safe and effective; large prospective studies would be needed to validate these findings.

Sign in / Sign up

Export Citation Format

Share Document